| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.51 | 0.03 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.5 | 0.03 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.23 | 0.03 |
| mRNA | XAV-939 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.2 | 0.03 |